← Eichor
Study identifier: NCT05748808 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Use of Biofeedback and Virtual Reality as Facilitators of Emotional Recognition in the Treatment of Aggressive Outbursts

Condition: Passive-Aggressive Personality Disorder  ·  Sponsor: University of Seville

PhaseNA
Planned participants60
Who can joinAll sexes, 10 Years to 16 Years
Healthy volunteersNo

About this study

The methodology will be applied for the treatment of aggressive episodes. Many people show this kind of behavior associated with several psychological disorders like austistic spectrum disorder (ASD). It will be studied the effect of aggressive outbursts on several physiological signals (heart rate (HR), breathing rate (BR), electroencephalography (EEG), etc). The use of those signals in a biofeedback loop could help patients recognize their internal states and avoid imminent aggression. The study want to verify the efficacy of a cognitive therapy that includes biofeedback and virtual reality (VR) and find out the most significant physiological features that are affected by these episodes.

This description comes directly from the study's public registry record.

Talk to the study team

Isabel M Gomez-Gonzalez, Phd  ·  +34954552787  ·  igomez@us.es

Alberto J Molina-Cantero, PhD  ·  +34954552787  ·  almolina@us.es

Always discuss trial participation with your own doctor first.

Locations (1)

Universidad de SevillaSeville, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05748808